Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Genes (Basel) ; 14(10)2023 10 17.
Article in English | MEDLINE | ID: mdl-37895301

ABSTRACT

INTRODUCTION: Non-diabetic hypoglycemia (NDH) is a collective term including the multiple causes of hypoglycemic syndrome not due to diabetes mellitus. NDH may result from insulinoma, IGF-2-omas, hypocorticism, Hirata's disease, genital disorders of glucose metabolism, etc. One of the most common causes of NDH faced by an endocrinologist is insulinoma, which in turn can be part of the hereditary syndrome of multiple endocrine neoplasia type 1 (MEN1). Congenital disorders of glucose metabolism in adult patients, on the contrary, are diagnosed extremely rarely, since they usually manifest in childhood. This article presents a unique clinical case of a patient with NDH and genetically verified MEN1 in combination with congenital hyperinsulinism due to an ABCC8 gene mutation. CASE REPORT: A 43-year-old patient with hypoglycemic symptoms from childhood is presented, in whom multiple pancreatic tumors and fluctuations in glycemia from 38.7 mg/dL to 329.7 mg/dL (2.15 to 18.3 mmol/L) were detected in adulthood, but a mild course of hypoglycemic syndrome was noted. Numerous examinations that were performed to establish an accurate diagnosis are described, signs that served as a reason for expanding the complex of studies are indicated, possible pathogenetic mechanisms of the mild course of hypoglycemic syndrome and hyperglycemic conditions are discussed. CONCLUSION: This case report is original and highlights that we must always remain intolerant of the inexplicable. Conducting an extended gene study can help perform a correct diagnosis in complex cases.


Subject(s)
Congenital Hyperinsulinism , Insulinoma , Multiple Endocrine Neoplasia Type 1 , Adult , Humans , Multiple Endocrine Neoplasia Type 1/genetics , Insulinoma/genetics , Insulinoma/pathology , Germ-Line Mutation , Hypoglycemic Agents , Glucose , Sulfonylurea Receptors/genetics
2.
HLA ; 101(5): 548-549, 2023 05.
Article in English | MEDLINE | ID: mdl-36544258

ABSTRACT

The novel HLA-C*05:269 allele was characterized using next-generation sequencing technology.


Subject(s)
Genes, MHC Class I , HLA-C Antigens , Humans , Alleles , High-Throughput Nucleotide Sequencing , Histocompatibility Testing
SELECTION OF CITATIONS
SEARCH DETAIL
...